InsidersTradesSigma
Follow the CYTOKINETICS, INCORPORATED share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was filed on 7 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Sung Lee. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
CYTOKINETICS, INCORPORATED is a biopharmaceutical company focused on developing treatments for muscle and heart diseases. It employs innovative approaches to enhance muscle function and physical performance.